2m 2m 2m 2m 2m 2m 2m
ZENAS BIOPHARMA (ZBIO)
NASDAQ
$29.16+$1.22 (+4.36%)
Price as of Oct 02, 2026 4:10 PM EDT- $1.8BMarket Cap
- 33.37%1-Year Change
- BiotechnologyIndustry
ZENAS BIOPHARMA (ZBIO)
$29.16+$1.22 (+4.36%)
ZBIO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $27.94 | ||
Change | +$0.97 (+3.60%) | ||
Open | $26.89 | ||
High | $29.23 | ||
Low | $26.55 | ||
Previous Close | $26.97 | ||
Volume | 881,855 | ||
30-Day Average Volume | 675,330 | ||
1-Week Change | 1.60% | ||
1-Month Change | -12.63% | ||
1-Year Change | 33.37% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 65.2M | ||
Total Assets | $701.7M | ||
Market Cap | $1.8B | ||
Enterprise Value | $1.9B | ||
Period: QTR TTM FY | |||
Revenue | $1.0M | ||
Net Income | -$111.5M | ||
Free Cash Flow | -$57.2M | ||
EBIT | -$109.6M | ||
EBITDA | -$109.6M | ||
Net Working Capital | $588.0M | ||
EPS | -$1.77 | ||
Enterprise Value/EBITDA | -18 | ||
Enterprise Value/Revenue | 1,921 | ||
P/B | 7 | ||
P/E | -16 | ||
PEG | 1 | ||
Price/Free Cash Flow | -32 | ||
Price/Operating Cash Flow | -32 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 12/24/2019 | ||
Last Split Factor | 1 : 2 | ||
Last Split Date | 05/24/2018 | ||
Earnings & Revenue